Competing-risk outcomes after hematopoietic stem cell transplantation from the perspective of time-dependent effects
EHA Library. Fuerst D. Sep 1, 2018; 234233 Topic: 2B Acute myeloid leukemia (AML) and leukemias of ambiguous lineage
Dr. Daniel Fuerst
Dr. Daniel Fuerst
Contributions
×

By continuing to browse or by clicking “Accept Terms & all Cookies”, you agree to the storing of third-party cookies on your device to enhance your user experience and agree to the user terms and conditions of this learning management system (LMS).

Cookie Settings
Accept Terms & all Cookies